Advanced

Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population.

Tatlisumak, Turgut; Putaala, Jukka; Innilä, Markus; Enzinger, Christian; Metso, Tiina M; Curtze, Sami; von Sarnowski, Bettina; Amaral-Silva, Alexandre; Jungehulsing, Gerhard Jan and Tanislav, Christian, et al. (2016) In Journal of Neurology 263(2). p.257-262
Abstract
Mitochondrial diseases, predominantly mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), may occasionally underlie or coincide with ischemic stroke (IS) in young and middle-aged individuals. We searched for undiagnosed patients with MELAS in a target subpopulation of unselected young IS patients enrolled in the Stroke in Young Fabry Patients study (sifap1). Among the 3291 IS patients aged 18-55 years recruited to the sifap1 study at 47 centers across 14 European countries, we identified potential MELAS patients with the following phenotypic features: (a) diagnosed cardiomyopathy or (b) presence of two of the three following findings: migraine, short stature (≤165 cm for males; ≤155 cm for females), and... (More)
Mitochondrial diseases, predominantly mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), may occasionally underlie or coincide with ischemic stroke (IS) in young and middle-aged individuals. We searched for undiagnosed patients with MELAS in a target subpopulation of unselected young IS patients enrolled in the Stroke in Young Fabry Patients study (sifap1). Among the 3291 IS patients aged 18-55 years recruited to the sifap1 study at 47 centers across 14 European countries, we identified potential MELAS patients with the following phenotypic features: (a) diagnosed cardiomyopathy or (b) presence of two of the three following findings: migraine, short stature (≤165 cm for males; ≤155 cm for females), and diabetes. Identified patients' blood samples underwent analysis of the common MELAS mutation, m.3243A>G in the MTTL1 gene of mitochondrial DNA. Clinical and cerebral MRI features of the mutation carriers were reviewed. We analyzed blood samples of 238 patients (177 with cardiomyopathy) leading to identification of four previously unrecognized MELAS main mutation carrier-patients. Their clinical and MRI characteristics were within the expectation for common IS patients except for severe hearing loss in one patient and hyperintensity of the pulvinar thalami on T1-weighted MRI in another one. Genetic testing for the m.3243A>G MELAS mutation in young patients with IS based on phenotypes suggestive of mitochondrial disease identifies previously unrecognized carriers of MELAS main mutation, but does not prove MELAS as the putative cause. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Neurology
volume
263
issue
2
pages
257 - 262
publisher
Steinkopff
external identifiers
  • pmid:26566914
  • scopus:84957946136
  • wos:000370270100008
ISSN
1432-1459
DOI
10.1007/s00415-015-7969-z
language
English
LU publication?
yes
id
6b658589-3f5c-4a29-8384-f3cfd173106b (old id 8235566)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26566914?dopt=Abstract
date added to LUP
2015-12-04 22:45:45
date last changed
2017-03-30 14:19:26
@article{6b658589-3f5c-4a29-8384-f3cfd173106b,
  abstract     = {Mitochondrial diseases, predominantly mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), may occasionally underlie or coincide with ischemic stroke (IS) in young and middle-aged individuals. We searched for undiagnosed patients with MELAS in a target subpopulation of unselected young IS patients enrolled in the Stroke in Young Fabry Patients study (sifap1). Among the 3291 IS patients aged 18-55 years recruited to the sifap1 study at 47 centers across 14 European countries, we identified potential MELAS patients with the following phenotypic features: (a) diagnosed cardiomyopathy or (b) presence of two of the three following findings: migraine, short stature (≤165 cm for males; ≤155 cm for females), and diabetes. Identified patients' blood samples underwent analysis of the common MELAS mutation, m.3243A>G in the MTTL1 gene of mitochondrial DNA. Clinical and cerebral MRI features of the mutation carriers were reviewed. We analyzed blood samples of 238 patients (177 with cardiomyopathy) leading to identification of four previously unrecognized MELAS main mutation carrier-patients. Their clinical and MRI characteristics were within the expectation for common IS patients except for severe hearing loss in one patient and hyperintensity of the pulvinar thalami on T1-weighted MRI in another one. Genetic testing for the m.3243A>G MELAS mutation in young patients with IS based on phenotypes suggestive of mitochondrial disease identifies previously unrecognized carriers of MELAS main mutation, but does not prove MELAS as the putative cause.},
  author       = {Tatlisumak, Turgut and Putaala, Jukka and Innilä, Markus and Enzinger, Christian and Metso, Tiina M and Curtze, Sami and von Sarnowski, Bettina and Amaral-Silva, Alexandre and Jungehulsing, Gerhard Jan and Tanislav, Christian and Thijs, Vincent and Rolfs, Arndt and Norrving, Bo and Fazekas, Franz and Suomalainen, Anu and Kolodny, Edwin H},
  issn         = {1432-1459},
  language     = {eng},
  number       = {2},
  pages        = {257--262},
  publisher    = {Steinkopff},
  series       = {Journal of Neurology},
  title        = {Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population.},
  url          = {http://dx.doi.org/10.1007/s00415-015-7969-z},
  volume       = {263},
  year         = {2016},
}